Skip to main navigation Skip to search Skip to main content

Mixture of experts based medication recommendation for multimorbidity

  • Jinhang Xu
  • , Changzhi Sun
  • , Wenqi Qian
  • , Zijing Tian
  • , Jianxin Tang
  • , Jing Zhang
  • , Yongjun Zheng*
  • , Shiliang Li*
  • , Honglin Li*
  • *Corresponding author for this work
  • Innovation Center for AI and Drug Discovery
  • East China Normal University
  • Shanghai Key Laboratory of New Drug Design
  • East China University of Science and Technology
  • Lingang Laboratory
  • Pharmacology Research Center
  • Fudan University
  • National Clinical Research Center for Aging and Medicine
  • Department of Pain Management
  • Huadong Hospital

Research output: Contribution to journal › Article › peer-review

Abstract

Medication combination recommendation aims to assist clinicians in providing rational treatment decisions based on patient clinical information, which remains challenging and error-prone, especially in multimorbidity scenarios. However, existing approaches often fail to generate comprehensive recommendations that integrate insights from multiple expert perspectives. To address this limitation, we propose Rx-Expert, a Mixture-of-Experts-based intelligent recommendation system designed to deliver accurate and interpretable medication combination suggestions. Rx-Expert consists of two complementary models: a coarse-grained model that simulates the real-world medical consultation process by training specialized expert networks for distinct recommendation tasks, and a fine-grained model that incorporates molecular representations and known drug-drug interaction information to support drug-level recommendation. Moreover, a Cross Fusion Module is introduced to integrate global, substructure, and textual molecular features, ensuring a holistic understanding of medication properties. Experimental results on the MIMIC-III, MIMIC-IV and eICU datasets demonstrate that our dual-track framework consistently outperforms existing baselines across all evaluation metrics. This work presents a practical and interpretable expert system that enhances clinical decision-making, particularly for patients with complex multimorbidity, by combining patient-specific routing, molecular drug representations, and known interaction constraints.

Original languageEnglish
Article number133374
JournalExpert Systems with Applications
Volume331
DOIs
StatePublished - 15 Dec 2026

Keywords

  • Clinical decision
  • Drug-drug interactions
  • Medication recommendation
  • MoE
  • Multimorbidity

Fingerprint

Dive into the research topics of 'Mixture of experts based medication recommendation for multimorbidity'. Together they form a unique fingerprint.

Cite this